Cost-Effectiveness Analysis of the South African Infant National Immunization Program for the Prevention of Pneumococcal Disease

被引:0
|
作者
Liping Huang
Cheryl L. McDade
Johnna E. Perdrizet
Michele R. Wilson
Sophie A. Warren
Susan Nzenze
Renilla Sewdas
机构
[1] Pfizer Inc.,School of Public Health
[2] RTI Health Solutions,undefined
[3] University of the Witwatersrand,undefined
[4] ZAF,undefined
[5] Health and Value,undefined
[6] Pfizer Laboratories (Pty) Ltd,undefined
[7] ZAF,undefined
来源
关键词
PCV; PCV13; PCV20; Pneumococcal disease; Vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:933 / 950
页数:17
相关论文
共 50 条
  • [21] Cost-effectiveness of dental caries prevention strategies in South African schools
    Micheal Kofi Boachie
    Mpho Molete
    Karen Hofman
    Evelyn Thsehla
    BMC Oral Health, 23
  • [22] Cost-effectiveness of dental caries prevention strategies in South African schools
    Boachie, Micheal Kofi
    Molete, Mpho
    Hofman, Karen
    Thsehla, Evelyn
    BMC ORAL HEALTH, 2023, 23 (01)
  • [23] Cost-effectiveness of adding new rotavirus vaccines to the national immunization program in Kyrgyzstan
    Flem, E. T.
    Latipov, R.
    Nurmativ, Z. S.
    Xue, Y.
    Kasymbekova, K. T.
    Rheingans, R.
    VACCINE, 2008,
  • [24] COST-EFFECTIVENESS OF ROTAVIRUS VACCINATION AS PART OF THE NATIONAL IMMUNIZATION PROGRAM FOR THAI CHILDREN
    Chotivitayatarakorn, Peeranath
    Chotivitayatarakorn, Pairoj
    Poovorawan, Yong
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2010, 41 (01) : 114 - 125
  • [25] Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea
    Zhang, Xu-Hao
    Leeuwenkamp, Oscar
    Oh, Kyu-Bin
    Lee, Young Eun
    Kim, Chul-Min
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (01) : 85 - 94
  • [26] COST-EFFECTIVENESS ANALYSIS OF A ROTAVIRUS IMMUNIZATION PROGRAM FOR THE UNITED-STATES
    SMITH, JC
    HADDIX, AC
    TEUTSCH, SM
    GLASS, RI
    PEDIATRICS, 1995, 96 (04) : 609 - 615
  • [27] COST OF PNEUMOCOCCAL INFECTIONS AND COST-EFFECTIVENESS ANALYSIS OF PNEUMOCOCCAL VACCINATION IN TURKEY
    Akin, L.
    Kaya, M.
    Altinel, S.
    Pehlivan, T.
    Durand, L.
    Tasset-Tisseau, A.
    VALUE IN HEALTH, 2009, 12 (03) : A113 - A114
  • [28] Cost-effectiveness analysis of the diabetes prevention program in a Spanish setting
    Palmer, AJ
    Roze, S
    Valentine, WJ
    Renaudin, C
    VALUE IN HEALTH, 2004, 7 (06) : 741 - 741
  • [29] Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10- or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria
    Sarah J. Pugh
    Mark A. Fletcher
    Apostolos Charos
    Lynda Imekraz
    Matt Wasserman
    Raymond Farkouh
    Infectious Diseases and Therapy, 2019, 8 : 63 - 74
  • [30] PCV20 for the prevention of invasive pneumococcal disease in the Mexican pediatric population: A cost-effectiveness analysis
    Huerta, Jose Luis
    Ta, An
    Vinand, Elizabeth
    Torres, Gustavo Ivan
    Wannaadisai, Warisa
    Huang, Liping
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2025, 21 (01)